Xolair 150 MG/ML syringeml

Ended Awarded

Contract number
SPE2DB24FX1KL
Awardee
Awarding agency
Obligated
$116,055

Award facts

Contract value 100% obligated
$116,055.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. under an unidentified contracting vehicle. The firm-fixed-price order, valued at one hundred sixteen thousand fifty-five dollars, is for the delivery of XOLAIR 150 MG/ML SYRINGEML to a location in Park Ridge, Illinois. The product, which contains the active ingredient omalizumab, will be delivered by November 6, 2023 without a set-aside designation. As the DLA's mission involves providing supplies to all branches of the U.S. military, this order for the allergy medication will likely support treatment of service members.

Quick answers

Who was awarded contract SPE2DB24FX1KL?

SPE2DB24FX1KL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 16, 2023.

How much is contract SPE2DB24FX1KL worth?

The government has obligated $116,055 on SPE2DB24FX1KL.

Is contract SPE2DB24FX1KL an order under another contract?

Yes. SPE2DB24FX1KL is a delivery order under SPE2DB22D9353, an indefinite delivery contract.

Was contract SPE2DB24FX1KL competed?

The extent of competition for SPE2DB24FX1KL was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award